Product Overview
The document describes the DUAL PATTY V, an innovative hydrofiber surgical patty developed by ENDOVISION. It is designed for the protection of vessels and nerves during surgery. The product is available in various sizes and is packaged in 10 packs per box. Key features include high absorption (12 times its weight), customized size and shape, easy flexibility, minimized particle release, easy removal, easy suction, stable adhesion, and a clear view.

Material and Technology
The surgical patty is made from HR-Chitosan (Hydron Reinforced Chitosan), a patented material by ENDOVISION. This material enhances chitosan's properties, including hemostasis, anti-microbial activity, toxic molecule adsorption, high absorption, and moisturizing effects.

Performance and Benefits
HR-Chitosan demonstrates 99.9% anti-bacterial activity against various bacteria, including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and MRSA. It provides rapid bleeding control through charge interactions and has a high blood clotting index (B.C.I). The material also suppresses inflammatory cytokines by up to 60% and offers more than 20 times absorption and moisturizing effect compared to its weight. Additionally, it deodorizes more than 99.8% of ammonia generated by proteolysis.

Comparative Analysis
Graphs and tables in the document compare HR-Chitosan with n-Chitosan and other competitors, highlighting superior performance in absorption, anti-microbial activity, and deodorization. HR-Chitosan consistently outperforms n-Chitosan in these areas.

Contact Information
ENDOVISION is located in Daegu, Republic of Korea, and can be contacted via phone or email for further inquiries.